AEGiS-UNAIDS: Financial resource requirements for AIDS

Important note: Information in this article was accurate in 2007. The state of the art may have changed since the publication date.

Financial resource requirements for AIDS

UNAIDS Press Release - September 27, 2007

UNAIDS has released a new report on the estimated financial resources required for the AIDS response. The report, entitled Financial Resources required to Achieve Universal Access to HIV, Prevention, Treatment, Care and Support puts forward three different approaches to financing the AIDS response including:

Scaling-up at current rates. By following the current rate of annual scale-up, the estimated resource requirements would be between US$ 14 - 18 billion in 2015, this amount would provide antiretroviral treatment for 8 million people in that year and the prevention, care, support and social mitigation targets would be far from Universal Access levels.

Universal Access by 2010. This approach envisages significant increases in available resources and an urgent and dramatic scale-up of coverage in all countries. Following this approach would provide antiretroviral treatment for 14 million people by 2010. To achieve this, the annual resource requirements would rise to between US$ 32 - 51 billion in 2010 and between US$ 45 - 63 billion by 2015. Prevention, care, support and social mitigation targets would also reach the targets consistent with universal access in 2010.

Phased scale-up to universal access by 2015. This approach assumes different rates of scale-up for each country based on current service coverage and capacity, with the achievement of different programmatic targets (prevention, care, treatment, support and social mitigation) at different times and the achievement of universal access by all countries by 2015. The approach would require between US$ 41 - 58 billion in 2015.

The estimates provided in the report, developed for 132 low- and middle-income countries, were based on the type of epidemic and nationally established targets using the latest available data.

070927
UN070916

Copyright © 2007 - Joint United Nations Programme on HIV/AIDS (UNAIDS). All rights reserved. UNAIDS articles, which are not formal publications of UNAIDS, may be freely reviewed, quoted, reproduced or translated, in part or in full, provided the source is acknowledged. The documents may not be sold or used in conjunction with commercial purposes without prior written approval from UNAIDS (contact: UNAIDS Information Centre).

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, the National Library of Medicine, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 2007. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2007. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .